Implementing and Evaluating a National Integrated Digital Registry and Clinical Decision Support System in Early Intervention in Psychosis Services (Early Psychosis Informatics Into Care): Co-Designed Protocol.

Early Intervention in Psychosis clinical decision support system co-design decision support digital registry mental health participatory participatory co-design psychiatry psychosis registry study protocol

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
19 Mar 2024
Historique:
received: 23 06 2023
accepted: 21 02 2024
revised: 21 01 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: epublish

Résumé

Early intervention in psychosis (EIP) services are nationally mandated in England to provide multidisciplinary care to people experiencing first-episode psychosis, which disproportionately affects deprived and ethnic minority youth. Quality of service provision varies by region, and people from historically underserved populations have unequal access. In other disease areas, including stroke and dementia, national digital registries coupled with clinical decision support systems (CDSSs) have revolutionized the delivery of equitable, evidence-based interventions to transform patient outcomes and reduce population-level disparities in care. Given psychosis is ranked the third most burdensome mental health condition by the World Health Organization, it is essential that we achieve the same parity of health improvements. This paper reports the protocol for the program development phase of this study, in which we aimed to co-design and produce an evidence-based, stakeholder-informed framework for the building, implementation, piloting, and evaluation of a national integrated digital registry and CDSS for psychosis, known as EPICare (Early Psychosis Informatics into Care). We conducted 3 concurrent work packages, with reciprocal knowledge exchange between each. In work package 1, using a participatory co-design framework, key stakeholders (clinicians, academics, policy makers, and patient and public contributors) engaged in 4 workshops to review, refine, and identify a core set of essential and desirable measures and features of the EPICare registry and CDSS. Using a modified Delphi approach, we then developed a consensus of data priorities. In work package 2, we collaborated with National Health Service (NHS) informatics teams to identify relevant data currently captured in electronic health records, understand data retrieval methods, and design the software architecture and data model to inform future implementation. In work package 3, observations of stakeholder workshops and individual interviews with representative stakeholders (n=10) were subject to interpretative qualitative analysis, guided by normalization process theory, to identify factors likely to influence the adoption and implementation of EPICare into routine practice. Stage 1 of the EPICare study took place between December 2021 and September 2022. The next steps include stage 2 building, piloting, implementation, and evaluation of EPICare in 5 demonstrator NHS Trusts serving underserved and diverse populations with substantial need for EIP care in England. If successful, this will be followed by stage 3, in which we will seek NHS adoption of EPICare for rollout to all EIP services in England. By establishing a multistakeholder network and engaging them in an iterative co-design process, we have identified essential and desirable elements of the EPICare registry and CDSS; proactively identified and minimized potential challenges and barriers to uptake and implementation; and addressed key questions related to informatics architecture, infrastructure, governance, and integration in diverse NHS Trusts, enabling us to proceed with the building, piloting, implementation, and evaluation of EPICare. DERR1-10.2196/50177.

Sections du résumé

BACKGROUND BACKGROUND
Early intervention in psychosis (EIP) services are nationally mandated in England to provide multidisciplinary care to people experiencing first-episode psychosis, which disproportionately affects deprived and ethnic minority youth. Quality of service provision varies by region, and people from historically underserved populations have unequal access. In other disease areas, including stroke and dementia, national digital registries coupled with clinical decision support systems (CDSSs) have revolutionized the delivery of equitable, evidence-based interventions to transform patient outcomes and reduce population-level disparities in care. Given psychosis is ranked the third most burdensome mental health condition by the World Health Organization, it is essential that we achieve the same parity of health improvements.
OBJECTIVE OBJECTIVE
This paper reports the protocol for the program development phase of this study, in which we aimed to co-design and produce an evidence-based, stakeholder-informed framework for the building, implementation, piloting, and evaluation of a national integrated digital registry and CDSS for psychosis, known as EPICare (Early Psychosis Informatics into Care).
METHODS METHODS
We conducted 3 concurrent work packages, with reciprocal knowledge exchange between each. In work package 1, using a participatory co-design framework, key stakeholders (clinicians, academics, policy makers, and patient and public contributors) engaged in 4 workshops to review, refine, and identify a core set of essential and desirable measures and features of the EPICare registry and CDSS. Using a modified Delphi approach, we then developed a consensus of data priorities. In work package 2, we collaborated with National Health Service (NHS) informatics teams to identify relevant data currently captured in electronic health records, understand data retrieval methods, and design the software architecture and data model to inform future implementation. In work package 3, observations of stakeholder workshops and individual interviews with representative stakeholders (n=10) were subject to interpretative qualitative analysis, guided by normalization process theory, to identify factors likely to influence the adoption and implementation of EPICare into routine practice.
RESULTS RESULTS
Stage 1 of the EPICare study took place between December 2021 and September 2022. The next steps include stage 2 building, piloting, implementation, and evaluation of EPICare in 5 demonstrator NHS Trusts serving underserved and diverse populations with substantial need for EIP care in England. If successful, this will be followed by stage 3, in which we will seek NHS adoption of EPICare for rollout to all EIP services in England.
CONCLUSIONS CONCLUSIONS
By establishing a multistakeholder network and engaging them in an iterative co-design process, we have identified essential and desirable elements of the EPICare registry and CDSS; proactively identified and minimized potential challenges and barriers to uptake and implementation; and addressed key questions related to informatics architecture, infrastructure, governance, and integration in diverse NHS Trusts, enabling us to proceed with the building, piloting, implementation, and evaluation of EPICare.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/50177.

Identifiants

pubmed: 38502175
pii: v13i1e50177
doi: 10.2196/50177
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e50177

Informations de copyright

©Siân Lowri Griffiths, Graham K Murray, Yanakan Logeswaran, John Ainsworth, Sophie M Allan, Niyah Campbell, Richard J Drake, Mohammad Zia Ul Haq Katshu, Matthew Machin, Megan A Pope, Sarah A Sullivan, Justin Waring, Tumelo Bogatsu, Julie Kane, Tyler Weetman, Sonia Johnson, James B Kirkbride, Rachel Upthegrove. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 19.03.2024.

Auteurs

Siân Lowri Griffiths (SL)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom.

Graham K Murray (GK)

Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
CAMEO, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.

Yanakan Logeswaran (Y)

Division of Psychiatry, University College London, London, United Kingdom.

John Ainsworth (J)

The University of Manchester, Manchester, United Kingdom.
NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Sophie M Allan (SM)

Department of Clinical Psychology and Psychotherapies, Medical School, University of East Anglia, Norwich, United Kingdom.
School of Health Sciences, University of East Anglia, Norwich, United Kingdom.

Niyah Campbell (N)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom.

Richard J Drake (RJ)

The University of Manchester, Manchester, United Kingdom.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, United Kingdom.

Mohammad Zia Ul Haq Katshu (MZUH)

Institute of Mental Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, United Kingdom.

Matthew Machin (M)

The University of Manchester, Manchester, United Kingdom.

Megan A Pope (MA)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom.

Sarah A Sullivan (SA)

Centre for Academic Mental Health, University of Bristol, Bristol, United Kingdom.
Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.

Justin Waring (J)

School of Social Policy, University of Birmingham, Birmingham, United Kingdom.

Tumelo Bogatsu (T)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom.

Julie Kane (J)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.

Tyler Weetman (T)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.

Sonia Johnson (S)

Division of Psychiatry, University College London, London, United Kingdom.
Camden and Islington NHS Foundation Trust, London, United Kingdom.

James B Kirkbride (JB)

Division of Psychiatry, University College London, London, United Kingdom.

Rachel Upthegrove (R)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom.
Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.

Classifications MeSH